SEC Form 4 · accession 0001140361-16-073887
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Clemmer
Officer — President and CEO · Director
Period of report
Jul 27, 2016
Accepted (ET)
Jul 29, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 27, 2016 | A | 21,191 | $0.00 | A | 71,191 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $16.59 | Jul 27, 2016 | A | 74,642 | A | Jul 27, 2017 | Jul 27, 2023 | Common Stock | 74,642 | 74,642 | D |
Explanation of responses
- F1This acquisition of 21,191 shares of common stock ("Common Stock") of AngioDynamics, Inc.(the "Company"), represents 21,191 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 27, 2017, such that 25% of the restricted stock units will vest on each of July 27, 2017, 2018, 2019 and 2020.
- F2These stock options vest in four equal annual installments beginning on July 27, 2017, such that 25% of the options will vest on each of July 27, 2017, 2018, 2019 and 2020.